EntitiesBioTechHemerion Therapeutics

Startup Dossier

Hemerion Therapeutics

Innovative technology for treating glioblastoma and advancing cancer therapies

active
Typestartup
SectorBioTech
LocationVilleneuve-d'Ascq

About

Innovative technology for treating glioblastoma and advancing cancer therapies

Structural DNA

Legal Name

Hemerion Therapeutics

SIREN

888737186

Founders & Team

Funding Lineage

Series A

Capital Cell (Lead)

€6.5M

Jun 2025

Programs

i-Lab

2020

Links